Joe Merola

New York University, New York, NY, United States 
"Joe Merola"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Furie R, Werth V, Merola J, et al. (2017) 83 Biib059, a monoclonal antibody targeting bdca2, demonstrates evidence of proof of biological activity in subjects with cutaneous lupus Lupus Science & Medicine. 4
Furie R, Werth V, Merola J, et al. (2017) SAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le Annals of the Rheumatic Diseases. 76: 857-857
Skougaard M, Jørgensen T, Rifbjerg-Madsen S, et al. (2017) OP0112 In psoriatic arthritis fatigue is driven by inflammation, disease duration, and chronic pain: an observational danbio registry study Annals of the Rheumatic Diseases. 76: 98-99
Kristensen L, Merola J, Dutz J, et al. (2017) SAT0437 Ixekizumab improves nail and skin lesions in patients with active psoriatic arthritis and prior tnf inadequate response Annals of the Rheumatic Diseases. 76: 937-937
Coates L, Gottlieb A, Merola J, et al. (2017) SAT0461 Characterisation of different low disease activity measurements in patients with psoriatic arthritis Annals of the Rheumatic Diseases. 76: 947-948
Duffin K, Merola J, Latella J, et al. (2017) LB956 Identifying a core domain set to assess psoriasis in clinical trials: Delphi survey of patients and healthcare professionals from the International Dermatology Outcome Measures Psoriasis Initiative Journal of Investigative Dermatology. 137
Hatsell S, Medina L, Merola J, et al. (2003) Plakoglobin is O-glycosylated close to the N-terminal destruction box. The Journal of Biological Chemistry. 278: 37745-52
See more...